Select Page

ivWatch Receives CE Mark for the ivWatch Model 400

Recent regulatory approvals and global certification pave the way for international distribution  HAMPTON, Va., August 29, 2018 – ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations,...

Health Canada Issues Medical Device License to ivWatch

Surveillance monitoring to advance IV therapy care now available in Canada HAMPTON, Va., August 2, 2018 – ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, was recently issued a...

In the News: The Terror of Medical Errors

ivWatch Discusses Never Events in Healthcare Purchasing News The Healthcare Purchasing News article with a focus on preventing never events states the exact number and nature of medical errors that occur annually is up for debate. Some events might be underreported...

In the News: Small Business, Big Impact

ivWatch Featured Among Big Impact Businesses in Hampton Roads ivWatch was featured among a carefully selected group of Hampton Roads-based companies in a special feature section of CoVa BIZ Magazine. The article introduces the company’s history with...
ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

This form does not exist

You have Successfully Subscribed!

Pin It on Pinterest